[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2640 followers Created: 2025-07-22 12:02:11 UTC $ATYR aTyr Pharma reports completion of Phase X EFZO-FITâ„¢ study of Efzofitimod in patients with pulmonary sarcoidosis. Last patient visit announced. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$atyr](/topic/$atyr) [Post Link](https://x.com/OzmosiHealth/status/1947628237364072806)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2640 followers
Created: 2025-07-22 12:02:11 UTC
$ATYR aTyr Pharma reports completion of Phase X EFZO-FITâ„¢ study of Efzofitimod in patients with pulmonary sarcoidosis. Last patient visit announced.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1947628237364072806